1 results match your criteria: "Cooperative Clinical Drug Research and Development (CRO)[Affiliation]"
Eur J Clin Pharmacol
October 1996
Cooperative Clinical Drug Research and Development (CRO), Berlin, Germany.
This study was conducted to investigate the effect of diprafenone on the steady-state pharmacokinetics of digoxin. Twelve healthy men, all rapid hydroxylators of debrisoquine, received digoxin (0.5 mg per day over 7 days with a loading dose of 2 x 1 mg) or digoxin and diprafenone (3 x 100 mg per day) in three different phases, without a wash-out period (phase 1, digoxin alone; phase 2, digoxin + diprafenone; phase 3, digoxin alone).
View Article and Find Full Text PDF